1-3 of 3 results for subject:Patients
Librarians' tools
- Search time
- 0.138 seconds
- Solr query time
- 0.003 seconds
- Search query
- subject:Patients
- We searched for
- subject_t:Patients OR subject_t:"Sick people" OR subject_ses:92375
Type
House
Session
Year
Department
Member
Primary member
More
Winterton, Nicholas (3)
Answering member
Legislative stage
Legislation
Subject
More
Publisher
To ask the Secretary of State for Work and Pensions, what steps his Department is taking to ensure that cancer patients are offered specialist benefits advice at diagnosis; and if he will make a statement; how many cancer sufferers who have subsequently died from their illness did not receive (a)...
To ask the Secretary of State for Work and Pensions, what steps his Department is taking to ensure that cancer patients are offered specialist benefits advice at diagnosis; and if he will make a statement; how many cancer sufferers who have subsequently died from their illness did not receive (a)...
Asked by
Nicholas Winterton
(Conservative)
Answered by
Maria Eagle
(Labour)
Answering body
Department for Work and Pensions
Type
Written questions
Status
Answered
Tabled on
11 November 2004
For answer on
18 November 2004
Answered on
18 November 2004
Sir Nicholas Winterton: To ask the Secretary of State for Work and Pensions (1) what steps his Department is taking to ensure that
cancer patients are offered specialist benefits advice at diagnosis; and if he will make a statement; [198208]
(2) how many cancer sufferers who have subsequently died from their illness did not receive (a) disability living allowance
and (b) attendance allowance in each of the last five years for which figures are available; [198209]
(3) how many cancer sufferers without terminal diagnosis are not receiving (a) disability living allowance and
(b) attendance allowance; [198210]
(4) if he will make a statement on the (a) operation and (b) take-up of the special rules gateway governing
eligibility for higher rates of (i) disability living allowance and (ii) attendance allowance for patients with terminal illness;
[198211]
(5) what steps his Department is taking to publicise the entitlement link between (a) disability living allowance and
(b) attendance allowance and (i) carer's allowance and (ii) income support; [198212]
(6) if he will make it his Department's policy (a) to waive the three to six month qualifying period for cancer patients
claiming disability living allowance and attendance allowance and (b) to permit hospital in- patients to keep their (i)
disability living allowance and (ii) attendance allowance for 52 weeks; [198213]
(7) if he will revoke the 28-day linking rule for (a) disability living allowance and (b) attendance allowance
claimants who are hospitalised; and if he will change the definition of terminal illness from six to 12 months. [198214]
Maria Eagle: The Department has special arrangements that recognise the particular difficulties faced by people who have only a
short time to live, whether due to cancer or any other progressive disease. People in these circumstances are awarded attendance
allowance or the highest rate of the care component of disability living allowance automatically without having to satisfy a
qualifying period, and without having to complete a claim form to demonstrate their care needs. These arrangements ensure that
claims are dealt with quickly and sensitively.
In the year ending 31 May 2004 15,800 new claims were awarded under special rules and at the 31 may 2004 88,200 people were
receiving either disability living allowance or attendance allowance under the Special Rules. On average it takes less than six days
to make an award in these cases.
Advice about benefits is widely available from a range of sources including social security or Jobcentre Plus offices, post offices,
doctors' surgeries and other advice agencies to ensure that people who are disabled can make informed decisions about whether or not
to claim disability benefits.
Additionally, leaflets explaining the links between disability benefits and carers allowance and income support are sent directly to
customers when they are notified about their award of benefit.
Officials have met with Macmillan cancer relief to discuss their report and will be holding further discussions with them about the
scope for measures that will help people with cancer to receive benefits advice at the earliest opportunity.
Information is not available on how many people with cancer who subsequently died from that illness did not receive disability
living allowance or attendance allowance nor is information available as to how many people with cancer who do not have a terminal
diagnosis are not receiving these benefits.
There are no plans to change the definition of terminal illness or the rules governing the payment of disability living allowance
and attendance allowance to people in hospital.
Subjects
Disability living allowance; Benefits rules; Cancer; Advisory services; Chronic illnesses; Attendance allowance; Carers' benefits; Income support; Hospitals; Eligibility; Patients; Publicity; Recipients; Social security benefits; Take-up
Date
18 November 2004
Reference
426 c1896-7W;426 c1901-2W; 198208;198209;198210;198211;198212;198213;198214
House
House of Commons
To ask the Secretary of State for Health, if he will make it his policy to make anti-dementia drugs freely available on the NHS for all Alzheimer's disease sufferers; and if he will make a statement.
To ask the Secretary of State for Health, if he will make it his policy to make anti-dementia drugs freely available on the NHS for all Alzheimer's disease sufferers; and if he will make a statement.
Asked by
Nicholas Winterton
(Conservative)
Answered by
Stephen Ladyman
(Labour)
Answering body
Department of Health
Type
Written questions
Status
Answered
Tabled on
3 November 2004
For answer on
16 November 2004
Answered on
16 November 2004
Sir Nicholas Winterton: To ask the Secretary of State for Health if he will make it his policy to make anti- dementia drugs freely
available on the NHS for all Alzheimer's disease sufferers; and if he will make a statement. [196929]
Dr. Ladyman: In 2000, the National Institute for Clinical Excellence (NICE) recommended to the national health service that the
three drugs: donepezil, rivastigmine and galantamine should be made available in the NHS as one part of the management of some
people with mild and moderate Alzheimer's disease. Not all people taking one of these drugs will benefit from them. For those who do
not show improvement, or a slowing down of the disease in the first few months, it is unlikely that they would show any benefit
later on.
NICE is currently reviewing the original appraisal and recommendations, including looking at whether a fourth drug, memantine,
should also be made generally available.
Subjects
Concessions; Alzheimer's disease; Drugs; NHS; Patients; Prescription drugs; Prescriptions
Date
16 November 2004
Reference
426 c1369-70W;426 c1373-4W; 196929
House
House of Commons
To ask the Secretary of State for Health, what action he is taking to reduce waiting and delivery times for diagnostic equipment. (Failed OPQ).
To ask the Secretary of State for Health, what action he is taking to reduce waiting and delivery times for diagnostic equipment. (Failed OPQ).
Asked by
Nicholas Winterton
(Conservative)
Answered by
Lord Hutton of Furness
(Labour)
Answering body
Department of Health
Type
Written questions
Status
Answered
Tabled on
8 September 2004
For answer on
14 September 2004
Answered on
14 September 2004
Sir Nicholas Winterton: To ask the Secretary of State for Health what action he is taking to reduce waiting and delivery times for
diagnostic equipment. [188519]
Mr. Hutton: The national health service is committed to reducing the length of time that people wait before their treatment starts.
By 2008 patients will wait no longer than 18 weeks from general practitioner referral to the start of treatment and this includes
access to diagnostics.
Subjects
Access; Administrative delays; Diagnosis; Patients; Medical equipment; Waiting lists; Screening
Date
14 September 2004
Reference
424 c1496W;424 c1494W; 188519
House
House of Commons